UMCG

Running trials

• Not yet recruiting

  [¹⁸F]MC225 PET Analysis of Blood–Brain Barrier Function in Glioblastomas

  2026-526106-32-00· Phase 1· Source

• Recruiting

  Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer

  NCT07632079· Phase 2· Source

• Recruiting

  Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

  NCT07316621· Source

• Recruiting

  Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas

  NCT07071727· Source

• Recruiting

  To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

  NCT06970275· Source

• Recruiting

  TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer

  NCT06931769· Source

• Recruiting

  Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

  NCT06161818· Phase 2· Source

• Recruiting

  IMPT Dose Escalation for NSCLC (HyDose)

  NCT06484491· Source

• Recruiting

  Prospective Data Collection Initiative on Thoracic Malignancies

  NCT06996249· Source

• Not yet recruiting

  Diagnostic Electrical Cardioversion for Explaining Patient's AF and HF Symptoms

  NCT07000942· Source

• Recruiting

  A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  NCT06976268· Phase 2/3· Source

• Recruiting

  a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure

  NCT06587854· Source

• Recruiting

  Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.

  NCT07206017· Source

• Recruiting

  Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan.

  2024-514489-38-01· Phase 2· Source

• Recruiting

  Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF

  NCT06199180· Source

• Recruiting

  Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men

  NCT06200311· Source

• Recruiting

  Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era

  NCT07292805· Source

• Recruiting

  PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action

  NCT05938738· Source

• Recruiting

  Dutch Registry of Pediatric Cardiac Arrest

  NCT06938009· Source

• Recruiting

  MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose finding study using Cetuximab-IRDye800CW- combined with 5-ALA

  NCT05929456· Phase 1· Source

• Recruiting

  Iodine Uptake After a Low Iodine Diet

  NCT05599139· Source

• Recruiting

  Prediction Models for Complications After CRT in Esophageal Cancer

  NCT06366828· Source

• Recruiting

  National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

  NCT05326620· Source

• Recruiting

  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  NCT04628026· Phase 3· Source

• Active, not recruiting

  Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

  NCT04597671· Phase 3· Source

• Active, not recruiting

  A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT05160584· Source

• Recruiting

  Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

  NCT05463757· Source

• Recruiting

  PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

  NCT04642027· Phase 3· Source

• Active, not recruiting

  SELUTION SLR™ 014 In-stent Restenosis

  NCT04280029· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation3 recruiting
• Gastric and esophageal cancer3 recruiting
• Childhood cancers2 recruiting
• Glioblastoma2 recruiting
• Heart failure2 recruiting
• Lung cancer2 recruiting
• Prostate cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukemia1 recruiting
• Asthma1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Parkinson disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoma1 recruiting
• Thyroid cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis

  NCT07708779· Phase 1· Source

• Completed

  Fatigue in MS: From Invisible to Measurable

  NCT07182903· Source

• Completed

  The TransCatheter Valve and Vessels Trial

  NCT03424941· Source

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· Source